At a Glance
| 5F-PB-22 | Cannabidiol | |
|---|---|---|
| Class | Cannabinoid | Cannabinoid |
| Common Dose (oral) | 3–5 mg | 15–30 mg |
| Total Duration | — | 0.3–0.5 hrs |
| Routes | oralsmoked | oral |
5F-PB-22, a Cannabinoid, and Cannabidiol, a Cannabinoid, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Cannabinoids, meaning they share a common pharmacological foundation. They share 7 documented effects in common, with 23 effects unique to 5F-PB-22 and 7 unique to Cannabidiol. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 5F-PB-22 | Cannabidiol | |
|---|---|---|
| Class | Cannabinoid | Cannabinoid |
| Common Dose (oral) | 3–5 mg | 15–30 mg |
| Total Duration | — | 0.3–0.5 hrs |
| Routes | oralsmoked | oral |
| Effects | 30 documented | 14 documented |
| Level | 5F-PB-22 | Cannabidiol |
|---|---|---|
| Threshold | 1 mg | 2 mg |
| Light | 1–3 mg | 5–15 mg |
| Common | 3–5 mg | 15–30 mg |
| Strong | 5–8 mg | 30–60 mg |
| Heavy | 8 mg | 60 mg |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 1–3 mg |
| Common | 3–5 mg |
| Strong | 5–8 mg |
| Heavy | 8 mg |
5F-PB-22
Cannabidiol
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.